Live at 3PM: The fallout from RFK's ACIP firings, with ex-CDC director Mandy Cohen
Photo: Kyle LaHucik for Endpoints News
May 31, 2024 03:45 PM EDTUpdated January 2, 10:29 AM
R&D

Im­muno­core un­veils ear­ly-stage da­ta of skin can­cer treat­ment that led it to start Phase 3 tri­al

Lei Lei Wu

News Reporter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Up­dat­ed: Oma­da Health rose 21% in its pub­lic mar­ket de­but

Ex­clu­sive: Re­boot­ing dead hu­man brains, a biotech start­up seeks to rein­vent ear­ly drug test­ing work

Re­cur­sion to lay off 20% of staff, a month af­ter slash­ing its pipeline

Ex­clu­sive: Scor­pi­on spin­out gets $177M for stealthy pipeline amid Chi­na com­pe­ti­tion

Odyssey pulls back from IPO plans as pub­lic mar­kets re­main frozen

sponsored

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

A service from the Financial Times